Related Experiment Video
Updated: Apr 21, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.7K
Nausea in specific phobia of vomiting
Yvonne Höller1, Mark Van Overveld2, Heili Jutglar1
1Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, Ignaz-Harrer-Street 79, Salzburg 5020, Austria.
Behavioral Sciences (Basel, Switzerland)
|November 8, 2014
Summary
Nausea is a central symptom in specific phobia of vomiting (SPOV), significantly linked to fear intensity, duration, and lower body weight. Understanding nausea
Area of Science:
- Psychiatry and Psychology
- Clinical Psychology
- Medical Psychology
Background:
- Specific phobia of vomiting (SPOV) is a debilitating condition characterized by significant psychosocial impairment.
- Nausea is a primary symptom that often prompts individuals with SPOV to seek medical attention.
- The precise role of nausea in the development and manifestation of SPOV requires further investigation.
Purpose of the Study:
- To analyze the symptom of nausea in individuals with specific phobia of vomiting.
- To examine the relationship between nausea severity and key characteristics of the phobia, including fear intensity, duration, and body mass index.
Main Methods:
- An internet-based survey was conducted within a German SPOV online forum.
- Participants (N = 131) were categorized into high-nausea and low-nausea groups based on a calculated nausea score.
- Statistical analyses were performed to compare characteristics between the high- and low-nausea groups.
Main Results:
- Nausea is a common symptom among individuals with a fear of vomiting.
- The high-nausea group reported significantly higher subjective fear intensity and a longer duration of their phobia compared to the low-nausea group.
- A greater proportion of participants in the high-nausea group had a body mass index below 19.
Conclusions:
- Nausea appears to be a core symptom in specific phobia of vomiting, strongly associated with fear intensity, phobia duration, and body weight.
- Findings suggest that nausea plays a significant role in the clinical presentation of SPOV.
- Future research should explore the efficacy of nausea-specific treatment designs for improving therapeutic outcomes in SPOV.
More Related Videos
Related Concept Videos
01:22Pathophysiology of Vomiting
4.5K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.5K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.2K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
793
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
793
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
929
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
929
01:09Preparedness and Phobias
451
Human fear responses to certain stimuli, such as darkness, heights, deep water, and blood, can often arise despite the absence of direct negative experiences. This phenomenon is rooted in evolutionary psychology, which posits that humans have developed a predisposition to fear stimuli that historically posed significant survival threats. This predisposition, known as preparedness, suggests that early humans who developed a fear of potentially dangerous entities, such as venomous snakes and...
451
01:14Conditioned Taste Aversion
1.8K
Conditioned taste aversion, also known as sauce béarnaise syndrome, is a phenomenon in which an individual develops an aversion to a certain food taste following a negative experience, typically illness. This form of aversion is a type of classical conditioning in which the taste of the food (conditioned stimulus, CS) is associated with the experience of illness (unconditioned stimulus, UCS).
A notable characteristic of conditioned taste aversion is that it often requires only a single...
A notable characteristic of conditioned taste aversion is that it often requires only a single...
1.8K